Literature DB >> 21702009

Changes in Rab3D expression and distribution in the acini of Sjögren's syndrome patients are associated with loss of cell polarity and secretory dysfunction.

Verónica Bahamondes1, Amelina Albornoz, Sergio Aguilera, Cecilia Alliende, Claudio Molina, Isabel Castro, Ulises Urzúa, Andrew F G Quest, María-José Barrera, Sergio González, Marianela Sánchez, Steffen Härtel, Marcela Hermoso, Cecilia Leyton, María-Julieta González.   

Abstract

OBJECTIVE: Oral and ocular dryness are frequent and serious symptoms of Sjögren's syndrome (SS) that reflect problems in secretion due to glandular dysfunction. Exocytosis, an important process in the secretory pathway, requires the participation of Rab family GTPases. This study was undertaken to analyze the expression and localization of Rab3D and Rab8A and to examine their correlation with acinar cell polarity and glandular secretory function.
METHODS: Nineteen patients with SS and 17 controls were evaluated. Levels of Rab3D and Rab8A messenger RNA (mRNA) and protein were determined by real-time polymerase chain reaction and Western blotting. Subcellular localization of proteins was determined by indirect immunofluorescence analysis.
RESULTS: In patients with SS, total Rab3D protein levels decreased significantly, while mRNA levels remained unchanged. For Rab8A, no changes in either mRNA or protein levels were detected. In serous acini of labial salivary glands from patients with SS, the following 4 patterns of Rab3D staining were distinguishable: severely decreased, distribution throughout the cytoplasm, distribution throughout the cytoplasm combined with loss of nuclear polarity, and normal apical localization. Basal localization of Rab8A was not modified. Rab3D changes were accompanied by apicobasolateral redistribution of ezrin, loss of nuclear polarity, thicker Golgi stacks, and mucin 7 accumulation in the cytoplasm. Finally, low Rab3D protein levels correlated with alterations in scintigraphy measurements.
CONCLUSION: Our findings indicate that Rab3D regulates the exocytosis of many components critical for the maintenance of oral physiology. Hence, the changes observed in Rab3D expression and distribution are likely to contribute to the decrease in or loss of saliva components (i.e., mucins), which may explain the variety of oral and ocular symptoms associated with SS.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21702009     DOI: 10.1002/art.30500

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

Review 1.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

Review 2.  Advances in salivary gland gene therapy - oral and systemic implications.

Authors:  Bruce J Baum; Ilias Alevizos; John A Chiorini; Ana P Cotrim; Changyu Zheng
Journal:  Expert Opin Biol Ther       Date:  2015-07-06       Impact factor: 4.388

3.  Impaired GATE16-mediated exocytosis in exocrine tissues causes Sjögren's syndrome-like exocrinopathy.

Authors:  Akiko Suzuki; Chihiro Iwaya; Kenichi Ogata; Hiroki Yoshioka; Junbo Shim; Isei Tanida; Masaaki Komatsu; Norihiro Tada; Junichi Iwata
Journal:  Cell Mol Life Sci       Date:  2022-05-20       Impact factor: 9.261

4.  Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.

Authors:  Runzhong Fu; Srikanth Janga; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2021-09-03       Impact factor: 3.770

5.  Polymeric immunoglobulin receptor traffics through two distinct apically targeted pathways in primary lacrimal gland acinar cells.

Authors:  Shi Xu; Linlin Ma; Eunbyul Evans; Curtis T Okamoto; Sarah F Hamm-Alvarez
Journal:  J Cell Sci       Date:  2013-04-19       Impact factor: 5.285

6.  NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.

Authors:  Yaping Ju; Srikanth Reddy Janga; Wannita Klinngam; J Andrew MacKay; Dillon Hawley; Driss Zoukhri; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2018-09-08       Impact factor: 3.467

7.  Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.

Authors:  Zhen Meng; Maria C Edman; Pang-Yu Hsueh; Chiao-Yu Chen; Wannita Klinngam; Tanya Tolmachova; Curtis T Okamoto; Sarah F Hamm-Alvarez
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

8.  Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.

Authors:  Daniela Jara; Patricia Carvajal; Isabel Castro; María-José Barrera; Sergio Aguilera; Sergio González; Claudio Molina; Marcela Hermoso; María-Julieta González
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

9.  The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome.

Authors:  Tone B Enger; Arman Samad-Zadeh; Meghan P Bouchie; Kathrine Skarstein; Hilde K Galtung; Toshiyuki Mera; Janice Walker; A Sue Menko; Xaralabos Varelas; Denise L Faustman; Janicke L Jensen; Maria A Kukuruzinska
Journal:  Lab Invest       Date:  2013-09-30       Impact factor: 5.662

10.  Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.

Authors:  Zhen Meng; Wannita Klinngam; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.